Asset Management
Compare Stocks
4 / 10Stock Comparison
CWD vs JCAP vs ARES vs PRAA
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Credit Services
Asset Management
Financial - Credit Services
CWD vs JCAP vs ARES vs PRAA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Asset Management | Financial - Credit Services | Asset Management | Financial - Credit Services |
| Market Cap | $21M | $1.19B | $40.44B | $803M |
| Revenue (TTM) | $51M | $433M | $6.47B | $1.24B |
| Net Income (TTM) | $-21M | $140M | $527M | $-305M |
| Gross Margin | 48.2% | 71.2% | 74.8% | 99.2% |
| Operating Margin | -26.0% | 50.8% | 27.2% | 33.9% |
| Forward P/E | — | 7.2x | 20.2x | 25.9x |
| Total Debt | $82M | $1.19B | $14.91B | $32M |
| Cash & Equiv. | $2M | $36M | $1.50B | $104M |
CWD vs JCAP vs ARES vs PRAA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 25 | May 26 | Return |
|---|---|---|---|
| CaliberCos Inc. (CWD) | 100 | 27.2 | -72.8% |
| Jefferson Capital, … (JCAP) | 100 | 110.6 | +10.6% |
| Ares Management Cor… (ARES) | 100 | 71.1 | -28.9% |
| PRA Group, Inc. (PRAA) | 100 | 141.6 | +41.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CWD vs JCAP vs ARES vs PRAA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CWD lags the leaders in this set but could rank higher in a more targeted comparison.
JCAP carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 1.21, current ratio 20.16x
- Beta 1.21, yield 3.0%, current ratio 20.16x
- Lower P/E (7.2x vs 20.2x)
- Efficiency ratio 0.2% vs CWD's 0.7% (lower = leaner)
ARES is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 7 yrs, beta 1.62, yield 6.6%
- Rev growth 66.6%, EPS growth -5.3%
- 9.3% 10Y total return vs JCAP's 13.9%
- 66.6% NII/revenue growth vs CWD's -43.8%
PRAA is the clearest fit if your priority is momentum.
- +57.2% vs CWD's -79.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 66.6% NII/revenue growth vs CWD's -43.8% | |
| Value | Lower P/E (7.2x vs 20.2x) | |
| Quality / Margins | Efficiency ratio 0.2% vs CWD's 0.7% (lower = leaner) | |
| Stability / Safety | Beta 1.21 vs CWD's 1.84, lower leverage | |
| Dividends | 6.6% yield, 7-year raise streak, vs JCAP's 3.0%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +57.2% vs CWD's -79.8% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs CWD's 0.7% |
CWD vs JCAP vs ARES vs PRAA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CWD vs JCAP vs ARES vs PRAA — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JCAP leads in 2 of 6 categories
ARES leads 2 • PRAA leads 1 • CWD leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JCAP leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARES is the larger business by revenue, generating $6.5B annually — 126.6x CWD's $51M. JCAP is the more profitable business, keeping 24.3% of every revenue dollar as net income compared to CWD's -38.7%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $51M | $433M | $6.5B | $1.2B |
| EBITDAEarnings before interest/tax | -$7M | $137M | $1.8B | $431M |
| Net IncomeAfter-tax profit | -$21M | $140M | $527M | -$305M |
| Free Cash FlowCash after capex | -$7M | $265M | $1.5B | -$90M |
| Gross MarginGross profit ÷ Revenue | +48.2% | +71.2% | +74.8% | +99.2% |
| Operating MarginEBIT ÷ Revenue | -26.0% | +50.8% | +27.2% | +33.9% |
| Net MarginNet income ÷ Revenue | -38.7% | +24.3% | +8.2% | -24.6% |
| FCF MarginFCF ÷ Revenue | +1.1% | +37.4% | +23.9% | -7.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | — | -80.9% | +2.1% |
Valuation Metrics
PRAA leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 11.3x trailing earnings, JCAP trades at a 82% valuation discount to ARES's 62.8x P/E. On an enterprise value basis, PRAA's 1.7x EV/EBITDA is more attractive than ARES's 26.9x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $21M | $1.2B | $40.4B | $803M |
| Enterprise ValueMkt cap + debt − cash | $101M | $2.3B | $53.9B | $731M |
| Trailing P/EPrice ÷ TTM EPS | -1.07x | 11.27x | 62.83x | -2.68x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 7.20x | 20.23x | 25.94x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 3.56x | — |
| EV / EBITDAEnterprise value multiple | — | 10.34x | 26.88x | 1.69x |
| Price / SalesMarket cap ÷ Revenue | 0.41x | 2.74x | 6.25x | 0.65x |
| Price / BookPrice ÷ Book value/share | 1.88x | 3.11x | 3.08x | 0.79x |
| Price / FCFMarket cap ÷ FCF | 38.04x | 7.34x | 26.19x | — |
Profitability & Efficiency
JCAP leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JCAP delivers a 34.9% return on equity — every $100 of shareholder capital generates $35 in annual profit, vs $-2 for CWD. PRAA carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to CWD's 7.27x. On the Piotroski fundamental quality scale (0–9), ARES scores 8/9 vs JCAP's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.3% | +34.9% | +6.2% | -26.0% |
| ROA (TTM)Return on assets | -25.3% | +8.1% | +1.9% | -5.9% |
| ROICReturn on invested capital | -5.4% | +12.6% | +6.1% | +11.2% |
| ROCEReturn on capital employed | -7.2% | +16.6% | +7.3% | +8.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 8 | 5 |
| Debt / EquityFinancial leverage | 7.27x | 3.12x | 1.71x | 0.03x |
| Net DebtTotal debt minus cash | $79M | $1.2B | $13.4B | -$72M |
| Cash & Equiv.Liquid assets | $2M | $36M | $1.5B | $104M |
| Total DebtShort + long-term debt | $82M | $1.2B | $14.9B | $32M |
| Interest CoverageEBIT ÷ Interest expense | -1.64x | 0.00x | 2.68x | 0.06x |
Total Returns (Dividends Reinvested)
ARES leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARES five years ago would be worth $26,021 today (with dividends reinvested), compared to $62 for CWD. Over the past 12 months, PRAA leads with a +57.2% total return vs CWD's -79.8%. The 3-year compound annual growth rate (CAGR) favors ARES at 18.1% vs CWD's -81.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -30.9% | -6.6% | -25.1% | +19.5% |
| 1-Year ReturnPast 12 months | -79.8% | +13.9% | -21.1% | +57.2% |
| 3-Year ReturnCumulative with dividends | -99.4% | +13.9% | +64.7% | -39.3% |
| 5-Year ReturnCumulative with dividends | -99.4% | +13.9% | +160.2% | -46.8% |
| 10-Year ReturnCumulative with dividends | -99.4% | +13.9% | +929.6% | -32.2% |
| CAGR (3Y)Annualised 3-year return | -81.6% | +4.4% | +18.1% | -15.3% |
Risk & Volatility
Evenly matched — JCAP and PRAA each lead in 1 of 2 comparable metrics.
Risk & Volatility
JCAP is the less volatile stock with a 1.21 beta — it tends to amplify market swings less than CWD's 1.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PRAA currently trades 92.6% from its 52-week high vs CWD's 2.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.84x | 1.21x | 1.62x | 1.82x |
| 52-Week HighHighest price in past year | $48.00 | $23.80 | $195.26 | $22.55 |
| 52-Week LowLowest price in past year | $0.87 | $15.98 | $95.80 | $10.25 |
| % of 52W HighCurrent price vs 52-week peak | +2.0% | +85.7% | +63.1% | +92.6% |
| RSI (14)Momentum oscillator 0–100 | 42.0 | 49.5 | 63.2 | 61.2 |
| Avg Volume (50D)Average daily shares traded | 153K | 300K | 3.7M | 449K |
Analyst Outlook
ARES leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: JCAP as "Buy", ARES as "Buy", PRAA as "Hold". Consensus price targets imply 44.0% upside for ARES (target: $177) vs 24.5% for PRAA (target: $26). For income investors, ARES offers the higher dividend yield at 6.56% vs JCAP's 3.03%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $27.00 | $177.38 | $26.00 |
| # AnalystsCovering analysts | — | 9 | 22 | 13 |
| Dividend YieldAnnual dividend ÷ price | — | +3.0% | +6.6% | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | 7 | 2 |
| Dividend / ShareAnnual DPS | — | $0.62 | $8.08 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +2.5% |
JCAP leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARES leads in 2 (Total Returns, Analyst Outlook). 1 tied.
CWD vs JCAP vs ARES vs PRAA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CWD or JCAP or ARES or PRAA a better buy right now?
For growth investors, Ares Management Corporation (ARES) is the stronger pick with 66.
6% revenue growth year-over-year, versus -43. 8% for CaliberCos Inc. (CWD). Jefferson Capital, Inc. Common Stock (JCAP) offers the better valuation at 11. 3x trailing P/E (7. 2x forward), making it the more compelling value choice. Analysts rate Jefferson Capital, Inc. Common Stock (JCAP) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CWD or JCAP or ARES or PRAA?
On trailing P/E, Jefferson Capital, Inc.
Common Stock (JCAP) is the cheapest at 11. 3x versus Ares Management Corporation at 62. 8x. On forward P/E, Jefferson Capital, Inc. Common Stock is actually cheaper at 7. 2x.
03Which is the better long-term investment — CWD or JCAP or ARES or PRAA?
Over the past 5 years, Ares Management Corporation (ARES) delivered a total return of +160.
2%, compared to -99. 4% for CaliberCos Inc. (CWD). Over 10 years, the gap is even starker: ARES returned +929. 6% versus CWD's -99. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CWD or JCAP or ARES or PRAA?
By beta (market sensitivity over 5 years), Jefferson Capital, Inc.
Common Stock (JCAP) is the lower-risk stock at 1. 21β versus CaliberCos Inc. 's 1. 84β — meaning CWD is approximately 52% more volatile than JCAP relative to the S&P 500. On balance sheet safety, PRA Group, Inc. (PRAA) carries a lower debt/equity ratio of 3% versus 7% for CaliberCos Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CWD or JCAP or ARES or PRAA?
By revenue growth (latest reported year), Ares Management Corporation (ARES) is pulling ahead at 66.
6% versus -43. 8% for CaliberCos Inc. (CWD). On earnings-per-share growth, the picture is similar: Jefferson Capital, Inc. Common Stock grew EPS -5. 2% year-over-year, compared to -535. 2% for PRA Group, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CWD or JCAP or ARES or PRAA?
Jefferson Capital, Inc.
Common Stock (JCAP) is the more profitable company, earning 24. 3% net margin versus -38. 7% for CaliberCos Inc. — meaning it keeps 24. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JCAP leads at 50. 8% versus -26. 0% for CWD. At the gross margin level — before operating expenses — PRAA leads at 99. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CWD or JCAP or ARES or PRAA more undervalued right now?
On forward earnings alone, Jefferson Capital, Inc.
Common Stock (JCAP) trades at 7. 2x forward P/E versus 25. 9x for PRA Group, Inc. — 18. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ARES: 44. 0% to $177. 38.
08Which pays a better dividend — CWD or JCAP or ARES or PRAA?
In this comparison, ARES (6.
6% yield), JCAP (3. 0% yield) pay a dividend. CWD, PRAA do not pay a meaningful dividend and should not be held primarily for income.
09Is CWD or JCAP or ARES or PRAA better for a retirement portfolio?
For long-horizon retirement investors, Ares Management Corporation (ARES) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (6.
6% yield, +929. 6% 10Y return). CaliberCos Inc. (CWD) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ARES: +929. 6%, CWD: -99. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CWD and JCAP and ARES and PRAA?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CWD is a small-cap quality compounder stock; JCAP is a small-cap high-growth stock; ARES is a mid-cap high-growth stock; PRAA is a small-cap quality compounder stock. JCAP, ARES pay a dividend while CWD, PRAA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.